Results 31 to 40 of about 1,050,190 (380)

Deletion of low molecular weight protein tyrosine phosphatase (Acp1) protects against stress-induced cardiomyopathy. [PDF]

, 2015
The low molecular weight protein tyrosine phosphatase (LMPTP), encoded by the ACP1 gene, is a ubiquitously expressed phosphatase whose in vivo function in the heart and in cardiac diseases remains unknown.
Al-Habeeb, Waleed, Al-Haffar, Kamar Mohamed Adib, Al-Mohanna, Falah, Alvarez, Roberto, Assiri, Abdullah, Awad, Salma Mahmoud, Belhaj, Karim, Bottini, Nunzio, Colak, Dilek, Jordan, Maria C, Kunhi, Muhammad, Liu, Yingge, Marashly, Qussay, Poizat, Coralie, Quijada, Pearl, Roos, Kenneth P, Stanford, Stephanie M, Sussman, Mark, Toko, Haruhiro, Wade, Fallou, Zahid, Israa   +20 more
core   +2 more sources

Hypocalcaemic cardiac failure [PDF]

Postgraduate Medical Journal, 1978
SummaryA 35-year-old patient who presented with recurrent chest infection, pulmonary oedema and cardiac failure was found to be grossly hypocalcaemic owing to previously undiagnosed hypoparathyroidism. The cardiac failure was not easily relieved by digoxin and diuretics but it quickly responded when the plasma calcium was restored to normal with ...
D. P. Brenton, A. B. Pollard, J. Gonzales   +2 more
openaire   +2 more sources

Plasma Cardiac Troponin I Concentration and Cardiac Death in Cats with Hypertrophic Cardiomyopathy [PDF]

, 2014
BACKGROUND: The use of cardiac biomarkers to assist in the diagnosis of occult and symptomatic hypertrophic cardiomyopathy (HCM) in cats has been established. There is limited data describing their prognostic utility in cats with HCM.
Abbott, Atkins, Bang, Blume, Chan, Christiaans, Coats, Connolly, Connolly, Connolly, Fernandes, Fox, Fox, Fox, Gersh, Geske, Herndon, Humm, Kittleson, Kubo, Kubo, Langhorn, Lefbom, Lyons, Maron, Maron, Maron, Moreno, Ohno-Machado, Oyama, Paige, Payne, Payne, Peacock, Perna, Perna, Rush, Schober, Schober, Schober, Singletary, Trehiou-Sechi, Wagner, Wess   +43 more
core   +1 more source

WarpPINN: Cine-MR image registration with physics-informed neural networks [PDF]

, 2022
Heart failure is typically diagnosed with a global function assessment, such as ejection fraction. However, these metrics have low discriminate power, failing to distinguish different types of this disease. Quantifying local deformations in the form of cardiac strain can provide helpful information, but it remains a challenge.
arxiv   +1 more source

Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach

npj Systems Biology and Applications, 2017
Cardiology: Heart Failure Medication Reduces Heart Size The new wonder drug in heart failure management, Sacubitril/Valsartan, rejuvenates the heart by preventing its dilation. Using data from myocardial infarction and heart failure samples, we generated
Oriol Iborra-Egea, Carolina Gálvez-Montón, Santiago Roura, Isaac Perea-Gil, Cristina Prat-Vidal, Carolina Soler-Botija, Antoni Bayes-Genis   +6 more
doaj   +1 more source

Fabry Disease Cardiomyopathy: A Review of the Role of Cardiac Imaging from Diagnosis to Treatment

Reviews in Cardiovascular Medicine, 2022
Fabry disease is a rare X-linked inherited lysosomal storage disorder caused by the absence or reduction of alfa-galactosidase A activity in lysosomes, resulting in accumulation of glycosphingolipids in various tissues.
Laura Fuertes Kenneally, María Isabel García-Álvarez, Eloísa Feliu Rey, Ana García Barrios, Vicente Climent-Payá   +4 more
doaj   +1 more source

Cardiac rehabilitation for heart failure: Do older people want to attend and are they referred? [PDF]

, 2014
Purpose Uptake of cardiac rehabilitation services by older people is suboptimal. Offering suitable services may increase participation. This study investigated older heart failure patients' preferences between hospital, community and home-based service ...
Balady, Baxter, Bethell, Booth, British Heart Foundation, Brown, Buttery, Buttery, Charlson, Cooper, Crombie, Davies, Dickstein, Frankfort-Nachmias, Grace, Hodkinson, Jackson, Kwok, Lorig, Mahoney, Mathiowetz, McMurray, National Institute for Cardiovascular Outcomes Research (NICOR), Nicol, Owan, Perrenoud, Proudfoot, Sims, Syddall, The Criteria Committee of the New York Heart Association, Zigmond   +30 more
core   +2 more sources

A Cell-Enriched Engineered Myocardial Graft Limits Infarct Size and Improves Cardiac Function

JACC: Basic to Translational Science, 2016
Myocardial infarction (MI) remains a dreadful disease around the world, causing irreversible sequelae that shorten life expectancy and reduce quality of life despite current treatment.
Isaac Perea-Gil, MS, Cristina Prat-Vidal, PhD, Carolina Gálvez-Montón, DVM, PhD, Santiago Roura, PhD, Aida Llucià-Valldeperas, PhD, Carolina Soler-Botija, PhD, Oriol Iborra-Egea, MS, Idoia Díaz-Güemes, DVM, PhD, Verónica Crisóstomo, DVM, PhD, Francisco M. Sánchez-Margallo, DVM, PhD, Antoni Bayes-Genis, MD, PhD   +10 more
doaj   +1 more source

COPD and cardiovascular disease [PDF]

, 2019
COPD is one of the major public health problems in people aged 40 years or above. It is currently the 4th leading cause of death in the world and projected to be the 3rd leading cause of death by 2020.
André, S., Areias, Vanda, Boléo-Tomé, J.P., Cardoso, J., Conde, B., Fragoso, E.   +5 more
core   +3 more sources

A case report of recessive restrictive cardiomyopathy caused by a novel mutation in cardiac troponin I (TNNI3)

BMC Medical Genetics, 2019
Background Restrictive cardiomyopathy is a rare cardiac disease, for which several genes including TNNT2, MYPN, FLNC and TNNI3 have been associated with its familial form.
Malena P. Pantou, Polyxeni Gourzi, Aggeliki Gkouziouta, Iakovos Armenis, Loukas Kaklamanis, Christianna Zygouri, Pantelis Constantoulakis, Stamatis Adamopoulos, Dimitrios Degiannis   +8 more
doaj   +1 more source